Thymosin Alpha 1 Peptide: Analysing a Sequence With No UV Handle

Most peptide labs have a default workflow: run the sample at 280 nm and 214 nm, check the mass, estimate concentration from absorbance. Thymosin alpha 1 peptide breaks two of those four steps. Its 28 residues contain no tryptophan, tyrosine or phenylalanine, so it gives essentially nothing at 280 nm, and a concentration read from A280 is meaningless. It is also strongly acidic, which changes how it dissolves and how it behaves on a column. This guide explains how to confirm identity and purity for this compound, and what a QC team should expect to see on a certificate when a multi-vial order comes in.

Thymosin alpha 1 peptide at a glance

The sequence, with its N-terminal acetyl group, is:

Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH

The peptide corresponds to the first 28 residues of a larger protein, prothymosin alpha, and was first characterised from thymus tissue extracts. It is also listed under its nonproprietary name, thymalfasin. Synthetic research material should match the published sequence exactly, acetyl group included.

Why the acetyl group is the first thing to check

The natural peptide is acetylated at the N-terminal serine. A synthetic version without that cap is a different molecule, 42 Da lighter. Incomplete acetylation during synthesis is the most likely way to produce it, and because the uncapped peptide differs only slightly in polarity, it can survive purification and sit close to the main peak.

When a certificate arrives, compare the reported mass with 3108.3 Da and look specifically for a companion near 3066 Da. A clean result at the right mass with no 42 Da neighbour is the most direct evidence the acetylation step worked.

Working without a 280 nm signal

At 280 nm, nearly all peptide absorbance comes from tryptophan and tyrosine side chains, plus a minor share from any disulfide bonds. Thymosin alpha 1 has none of these. A chromatogram at that wavelength is a flat line with, at most, whatever aromatic impurities happen to be present.

This has three practical consequences:

1. Purity must be measured at 214 nm. The peptide bond absorbs there, so every peptide species in the sample contributes. A purity figure quoted at 280 nm for this compound is not a purity figure at all.
2. Mobile-phase quality matters more. Acetonitrile, trifluoroacetic acid and trace contaminants in the water all absorb near 214 nm, producing baseline drift over a gradient. Well-run methods use high-grade solvents and a blank gradient for comparison.
3. Concentration cannot come from A280. The usual extinction-coefficient calculation gives zero for this sequence. Concentration of analytical solutions has to come from careful weighing corrected for net peptide content, or from amino acid analysis.

For a lab preparing standards from several vials of the same order, the third point is the one that catches people out. Record the net peptide content from the certificate where it is given, and use it consistently.

An acidic peptide in an acidic mobile phase

Nine acidic side chains against four lysines give the peptide a strongly negative net charge at neutral pH and an isoelectric point somewhere around pH 4. That profile explains two behaviours that surprise analysts used to basic peptides.

First, solubility. In plain water, or in the acidic conditions of a TFA gradient, many carboxyl groups pick up a proton, the net charge shrinks, and solubility drops well below what the residue count would predict. It usually dissolves more easily in a mildly basic or near-neutral buffered solution. Note the solvent used whenever you record a result, because recovery depends on it.

Second, peak shape. Basic peptides tail on silica because positively charged side chains grab residual silanols. Thymosin alpha 1, with only four lysines against nine acids, shows much less of that effect. A broad or tailing main peak on this compound is therefore more likely to reflect a closely eluting impurity than a column interaction.

Acidic peptides also ionise in negative-mode electrospray, and some labs use that as a secondary check alongside the usual positive-mode spectrum.

Deamidation and other slow changes

The C-terminal residue is asparagine. In aqueous solution, asparagine gradually deamidates to aspartate or isoaspartate, adding about 0.98 Da. The reaction speeds up at higher pH and temperature, which puts it in tension with the near-neutral buffers this peptide dissolves best in.

At roughly 3.1 kDa, a one-dalton shift sits inside the isotope envelope of the parent and is hard to resolve from intact mass alone. Chromatography usually does the job better: the deamidated species usually run at a marginally different retention time, showing up as a shoulder or a small separate peak. The three aspartates can also isomerise through a succinimide intermediate, with no mass change at all. A persistent shoulder on a thymosin alpha 1 chromatogram is therefore worth taking seriously and tracking over time.

For stored material, the practical advice is the same as for any deamidation-prone peptide: keep it lyophilised and cold until needed, prepare solutions shortly before analysis and log how long each solution was held.

Reading the mass spectrum

At this size, positive electrospray produces a series of charge states rather than a single ion. Using the average mass, the main species fall near:

• 2+ at about m/z 1555.2
• 3+ at about m/z 1037.1
• 4+ at about m/z 778.1

Deconvolution software reconstructs the neutral mass from this series. A certificate should make clear whether it is reporting raw ions or a deconvoluted value, and whether that value is average or monoisotopic.

Three names that are easily confused

• Thymosin alpha 1: a defined 28-residue acetylated peptide with one calculated mass.
• Thymosin beta-4: an unrelated 43-residue peptide that shares only the word “thymosin”, which refers to the tissue both were first found in. Our article on thymosin beta-4 and the TB-500 fragment covers that family.
• Thymalin: a thymus-derived peptide preparation rather than a single sequence, so it has no single formula or mass to check against.

Put the sequence and the expected mass on any purchase order, and a mix-up between these three becomes easy to catch at receiving.

Bulk Peptides does not currently carry thymosin alpha 1. The checks here are offered as a general reference for labs specifying it from any source.

This material is discussed purely as an in-vitro research compound and analytical subject. The article does not describe or support any use in humans or animals.